A Canadian drugmaker said its plant-based COVID-19 vaccine showed strong protection against the virus and will soon seek authorization at home and elsewhere. Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant. The company said it's also preparing to send its data to the World Health Organization. The Medicago study involved 24,000 adult volunteers who received either the vaccine or a dummy shot and were followed to track COVID-19 infections and complications. ———The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education.

Source: Forbes December 07, 2021 20:04 UTC